Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

PDA Presents the Future of Pharmaceutical/Biopharmaceutical Manufacturing at 2017 Annual Meeting

Parenteral Drug Association
Posted on: 15 Nov 16

PR Newswire

BETHESDA, Md., Nov. 15, 2016

BETHESDA, Md., Nov. 15, 2016 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) is making final preparations for its 2017 Annual Meeting: Manufacturing Innovation: The Next Wave of Sterile and Biopharmaceutical Science, Technologies, and Processing. The 2017 Annual Meeting takes place at the Anaheim Marriott, Anaheim, California, April 3-5. A large exhibition of technology partners and enablers will run parallel to the meeting, April 3-4.

Following the meeting, there will be a workshop on cell and gene therapy manufacturing and PDA Education courses.

Press passes are available for the Annual Meeting and Workshop for members of the press.

About PDA – Connecting People, Science and Regulation®

The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its 10,000 members worldwide. Go to to learn more.

Media Inquiries: Walt Morris, 301-656-5900, x. 148;

Logo -
Video -


To view the original version on PR Newswire, visit:

SOURCE Parenteral Drug Association

PR Newswire

Last updated on: 15/11/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.